Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)

v3.19.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Net sales $ 184,861 $ 163,973 $ 522,341 $ 462,739
Cost of sales 60,251 53,712 177,110 152,777
Gross margin 124,610 110,261 345,231 309,962
Operating expenses:        
Selling, general and administrative 64,968 53,285 195,622 175,349
Research and development 15,552 13,892 46,154 41,350
Total operating expenses 80,520 67,177 241,776 216,699
Operating income 44,090 43,084 103,455 93,263
Other income (expense) 5,787 (18,102) (14,226) (23,581)
Earnings before income taxes 49,877 24,982 89,229 69,682
Income tax expense (benefit) 5,223 5,244 9,617 (14,767)
Net earnings 44,654 19,738 79,612 84,449
Other comprehensive income:        
Foreign currency translation gain (loss) 5,232 2,297 (4,368) 10,787
Unrealized gain (loss) on derivative instruments - cash flow hedges (1,854) (5,769)
Unrealized gain (loss) on available-for-sale investments 38,659 22,286
Other comprehensive income (loss) 3,378 40,956 (10,137) 33,073
Comprehensive income $ 48,032 $ 60,694 $ 69,475 $ 117,522
Earnings per share:        
Basic (in dollars per share) $ 1.18 $ 0.53 $ 2.11 $ 2.25
Diluted (in dollars per share) 1.15 0.52 2.05 2.22
Cash dividends per common share: (in dollars per share) $ 0.32 $ 0.32 $ 0.96 $ 0.96
Weighted average common shares outstanding:        
Basic (in shares) 37,772 37,503 37,745 37,450
Diluted (in shares) 38,861 38,142 38,813 37,933